Siemens may sell dental businesses
German industrial conglomerate Siemens AG is looking to divest its dental business, but plans to retain the bulk of its Medical Engineering Group, contrary to rumors that have surfaced in the European press recently.Siemens reported April 21 that it is
German industrial conglomerate Siemens AG is looking to divest its dental business, but plans to retain the bulk of its Medical Engineering Group, contrary to rumors that have surfaced in the European press recently.
Siemens reported April 21 that it is looking for a merger partner or acquirer for its Dental Systems division in Bensheim, Germany, and Pelton & Crane subsidiary in Charlotte, NC. Siemens said the move was part of the group's ongoing effort to improve its competitiveness and cost structure (SCAN 3/19/97).
The company emphasized that it does not intend to divest the rest of Medical Engineering, however.
"There is no reason for deleting Medical Engineering from our core businesses," said Heinrich von Pierer, chairman of Siemens AG. "It is obvious that our medical portfolios...are subject to permanent development."
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.
